{"id":15204,"date":"2021-01-05T01:23:26","date_gmt":"2021-01-04T22:23:26","guid":{"rendered":"https:\/\/www.klimikdergisi.org\/\/2021\/01\/05\/hepatocellular-carcinoma-in-a-chronic-hepatitis-b-patient-with-suppressed-viral-replication\/"},"modified":"2021-01-05T01:23:26","modified_gmt":"2021-01-04T22:23:26","slug":"hepatocellular-carcinoma-in-a-chronic-hepatitis-b-patient-with-suppressed-viral-replication","status":"publish","type":"post","link":"https:\/\/www.klimikdergisi.org\/en\/2021\/01\/05\/hepatocellular-carcinoma-in-a-chronic-hepatitis-b-patient-with-suppressed-viral-replication\/","title":{"rendered":"Hepatocellular Carcinoma in a Chronic Hepatitis B Patient With Suppressed Viral Replication"},"content":{"rendered":"<h1>Abstract<\/h1>\n<p> Suppressing viral replication is the main intervention for prevention of hepatocellular carcinoma (HCC) development, which is one of the purposes of treatment of chronic hepatitis B. We report a case of HCC in a 73-year-old woman with chronic hepatitis B who was treated and whose viral replication was successfully suppressed with antiviral therapy. The patient had anti-HBe positivity and her viral load was 1.01&#215;106 IU\/mL. Telbivudine treatment led to a decrease of HBV DNA below the detection limit on the second month of the treatment. But her \u03b1-fetoprotein level increased (121 ng\/L) on the 30th month of the treatment. Magnetic resonance imaging showed a mass compatible with HCC on the liver and a biopsy revealed HCC. She was treated with chemo-embolization. Although viral suppression is achieved in patients with chronic hepatitis B, follow-up and HCC screening should be done regularly in patients who have HCC risk factors such as thrombocytopenia and older age, as in this case.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abstract Suppressing viral replication is the main intervention for prevention of hepatocellular carcinoma (HCC) development, which is one of the purposes of treatment of chronic hepatitis B. We report a case of HCC in a 73-year-old woman with chronic hepatitis B who was treated and whose viral replication was successfully suppressed with antiviral therapy. The [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5132],"tags":[3157,4564,4566],"class_list":["post-15204","post","type-post","status-publish","format-standard","hentry","category-case-report","tag-hepatitis-b-virus","tag-hepatocellular-carcinoma","tag-telbivudine"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts\/15204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/comments?post=15204"}],"version-history":[{"count":0,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts\/15204\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/media?parent=15204"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/categories?post=15204"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/tags?post=15204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}